HIV Drug Resistance Prevalence in Sub-Saharan Africa, 2010–2025
by Siyabonga Malinga·Updated 2mo ago
Available on 1 platform
Sign in to view source links and access this dataset
Description
2010 to 2025 study-level data quantifying HIV drug resistance among patients on antiretroviral therapy with virological failure in sub-Saharan Africa. The dataset was compiled by Siyabonga Malinga from systematic searches of PubMed/MEDLINE, SCOPUS, and Google Scholar, following PRISMA guidelines. Each record includes variables on study setting, population characteristics, treatment exposure, and resistance outcomes with prevalence estimates and confidence intervals.
Use Cases
Conduct reproducible meta-analysis based on study-level prevalence estimates and confidence intervals.
Perform comparative analyses of resistance patterns across regions and time periods based on the compiled study data.
Analyze trends in dual- and triple-class HIV drug resistance based on the reported drug-class outcomes.
Assess the quality of observational studies using the included critical appraisal scores.
Strengths
Data covers a 15-year time range from 2010 to 2025.
Includes prevalence estimates for overall HIVDR and by four antiretroviral drug classes (NNRTI, NRTI, PI, INSTI).
Systematically identified from multiple sources (PubMed/MEDLINE, SCOPUS, Google Scholar) using predefined criteria.
Structured to support reproducible meta-analysis and comparative analyses.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment.
Data may reflect geographic and temporal bias inherent to the source studies and search strategy.
Provenance
Source
figshare
Collection Method
Data were systematically identified from literature databases using predefined search criteria, screened per PRISMA guidelines, and extracted using a standardised template.
Time Range
2010–2025
Freshness
Last updated 2026-04-13 09:11:13; freshness should be verified.